Compare · NBIS vs TEM
NBIS vs TEM
Side-by-side comparison of Nebius Group N.V. (NBIS) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NBIS and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- NBIS is the larger of the two at $57.84B, about 6.9x TEM ($8.34B).
- Over the past year, NBIS is up 314.8% and TEM is down 27.5% - NBIS leads by 342.3 points.
- TEM has been more active in the news (33 items in the past 4 weeks vs 13 for NBIS).
- TEM has more recent analyst coverage (25 ratings vs 16 for NBIS).
PerformanceNBIS+314.82%TEM-27.51%
2025-06-09+0.00%2026-06-08
- Company
- Nebius Group N.V.
- Tempus AI Inc.
- Price
- $217.80-4.44%
- $48.56+4.72%
- Market cap
- $57.84B
- $8.34B
- 1M return
- +18.04%
- -1.76%
- 1Y return
- +314.82%
- -27.51%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2011
- 2024
- News (4w)
- 13
- 33
- Recent ratings
- 16
- 25
Latest NBIS
- Nebius chooses Kao Data's Harlow campus for major AI infrastructure deployment
- Nebius expands in UK with more NVIDIA-powered infrastructure, more customers, and more cloud capabilities for agentic and enterprise AI
- Chief Technology Officer Shtan Danila sold $3,746,448 worth of Class A Shares (15,678 units at $238.96) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 291,700 units (SEC Form 4)
- Chief Revenue Officer Boroditsky Marc sold $2,976,333 worth of Class A Shares (10,776 units at $276.20), decreasing direct ownership by 29% to 26,886 units (SEC Form 4) to cover withholding tax
- CFO Alonso Sanchez Maria Del Dado sold $416,786 worth of Class A Shares (1,509 units at $276.20), decreasing direct ownership by 11% to 12,672 units (SEC Form 4) (tax liability)
- BNP Paribas Exane initiated coverage on Nebius Group N.V. with a new price target
- Nebius to present at BofA Global Technology conference
- Amendment: SEC Form 20-F/A filed by Nebius Group N.V.
- General Counsel Tal Boaz sold $1,016,905 worth of Class A Shares (5,100 units at $199.39) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 80,754 units (SEC Form 4)
- Nebius and Bloom Energy partner to power AI infrastructure build-out
Latest TEM
- Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Epstein David R sold $12,350 worth of shares (250 units at $49.40) as part of a pre-agreed trading plan, decreasing direct ownership by 0.79% to 31,464 units (SEC Form 4)
- Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
- Wolfe Research resumed coverage on Tempus AI
- Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
- Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
- Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
- Tempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
- CEO and Chairman Lefkofsky Eric P sold $7,763,312 worth of shares (166,250 units at $46.70) as part of a pre-agreed trading plan (SEC Form 4)
- Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology